Natera CEO sells shares, receives 37,401 RSUs

Natera, Inc. director and CEO Steven Leonard Chapman reported both an equity award and share sales.

Rhea-AI Filing Summary

Natera, Inc. director and CEO Steven Leonard Chapman reported both an equity award and share sales. On February 27, 2026, he received 37,401 Restricted Stock Units (RSUs), which vest over four years starting March 1, 2027, with each RSU representing one common share. On March 2, 2026, he sold a total of 3,950 shares of common stock in three open-market transactions at weighted average prices around $199–$201 per share, executed under a pre-established Rule 10b5-1 trading plan adopted December 11, 2023 and amended December 2, 2024. Following these transactions, he directly held 156,607 common shares.

Insider Trade Summary

Net Seller: 3,950 shares

Net Sell 4 txns

Insider Chapman Steven Leonard

Role CEO AND PRESIDENT

Sold 3,950 shs ($790K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,122	$199.1737	$223K
Sale	Common Stock	2,463	$200.2406	$493K
Sale	Common Stock	365	$201.1767	$73K
Grant/Award	Common Stock	37,401	$0.00	$0.00

Holdings After Transaction: Common Stock — 156,607 shares (Direct)

Footnotes (6)

1. F1. Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on March 1, 2027 and the remaining RSUs vest in 12 equal quarterly installments thereafter.
2. F2. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
3. F3. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024.
4. F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.6500 to $199.5650 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.7150 to $200.6600 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.80 to $201.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Natera (NTRA) disclose for its CEO?

Natera disclosed that CEO Steven Leonard Chapman received RSUs and sold shares. He was granted 37,401 Restricted Stock Units on February 27, 2026 and then sold a total of 3,950 common shares in open-market trades on March 2, 2026.

How many Natera (NTRA) shares did the CEO sell and at what prices?

The CEO sold 3,950 Natera common shares. These were executed in three open-market transactions at weighted average prices of about $199.17, $200.24, and $201.18 per share, with each trade reported as having occurred within a specified intraday price range.

What equity award did Natera (NTRA) grant its CEO in this Form 4?

Natera granted CEO Steven Leonard Chapman 37,401 Restricted Stock Units. The RSUs were issued on February 27, 2026, vest over four years starting March 1, 2027, and each RSU represents a contingent right to receive one share of Natera’s common stock.

How do the Natera (NTRA) CEO’s RSUs vest over time?

The CEO’s 37,401 RSUs vest over four years. Twenty-five percent vest on March 1, 2027, and the remaining units vest in 12 equal quarterly installments thereafter, aligning the award’s full vesting with a multi-year service and performance horizon.

Were Natera (NTRA) CEO share sales made under a trading plan?

Yes, the CEO’s share sales were made under a Rule 10b5-1 plan. The Form 4 notes that the March 2, 2026 sales were effected pursuant to a pre-arranged trading plan adopted December 11, 2023 and later amended on December 2, 2024.

How many Natera (NTRA) shares does the CEO own after these transactions?

After the reported transactions, the CEO directly holds 156,607 common shares. This figure reflects the impact of the RSU grant and subsequent open-market sales disclosed in the Form 4, as of the last reported transaction date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 09:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chapman Steven Leonard

(Last) (First) (Middle)

C/O NATERA, INC.

13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)

AUSTIN TX 78753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO AND PRESIDENT

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		37,401(1)	A	(2)	160,557	D
Common Stock	03/02/2026		S		1,122(3)	D	$199.1737(4)	159,435	D
Common Stock	03/02/2026		S		2,463(3)	D	$200.2406(5)	156,972	D
Common Stock	03/02/2026		S		365(3)	D	$201.1767(6)	156,607	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on March 1, 2027 and the remaining RSUs vest in 12 equal quarterly installments thereafter.

2. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

3. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024.

4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.6500 to $199.5650 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.7150 to $200.6600 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.80 to $201.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Tami Chen, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.